Investors are pumping money into AI tools for health insurersnews2026-02-27T14:00:27+00:00February 27th, 2026|Endpoints News|
Benzylated backbone behind bulkiest N-heterocyclic carbene yetnews2026-02-27T12:46:00+00:00February 27th, 2026|Chemistry World|
Novo Nordisk’s ‘strategic conundrum’: How being anchored to the past could cost it the futurenews2026-02-27T12:11:21+00:00February 27th, 2026|Endpoints News|
Doug Ingram’s uneven legacy at Sarepta; Merck splits human health business, brings in Sanofi execnews2026-02-27T12:00:10+00:00February 27th, 2026|Endpoints News|
